Share

OLIGOCARE "EORTC Study 1811 E²-RADIatE: European Radiotherapy Infrastructure of EORTC-ESTRO" Cohort: OligoCare 1822- Pragmatic observational study to evaluate radical radiotherapy in patients with oligo-metastatic cancer"

Project objectives

The aim of the study is to collect information regarding the radiotherapy treatment of oligometastatic patients affected by lung, prostate and colorectal cancers undergoing radiotherapy with ablative purposes.

Start and end date

January 28, 2020 - In progress

Project Manager

Sara Ramella - Principal Investigator

Coordinating institution of the project

Sponsor of the study: EORTC (European Organization for Research and Treatment of Cancer)

Other Institutions involved

  • University of Turin
  • Careggi University Hospital, Florence
  • European Institute of Oncology, Milan
  • Sacred Heart “Negrar” Hospital, Verona
  • Humanitas Clinical Institute, Milan
  • Mauger Scientific Clinical Institutes, Pavia
 
 
magnifiercrossmenuchevron-downchevron-leftchevron-right